Back Bay Life Science Advisors and Gorrissen Federspiel Life Sciences Seminar
Leaders in life sciences and corporate law gather in Copenhagen on 10 October for to share and discuss best practices on sustaining thriving biotechs in the Nordic countries
Back Bay Life Science Advisors, a global strategy and financial advisory firm, has partnered with Denmark’s highly regarded corporate law firm and M&A experts, Gorrissen Federspiel, for a life science seminar on sustaining successful biotechs and mergers and acquisitions across borders for companies with roots in Denmark, Sweden, Finland and other Nordic regions.“The European life science industry continues to grow, as do the opportunities for collaboration and partnering across borders,” said Jonathan Gertler, CEO and Managing Partner, Back Bay Life Science Advisors. “These cross-border collaborations advance the work and goals of the life science community, and further strengthens business opportunities among neighbors and across the global biotech landscape.”Back Bay Life Science Advisors provides strategic and financial guidance to the world’s foremost life science organizations. Gorrissen Federspiel is highly experienced and regarded in corporate and commercial M&A with deep expertise in life sciences transactions. Bringing together this combined expertise, this session of discussion and networking will offer insights and lead discussions aimed at providing inspiration and practical advice.
Keynote sessions include:
Building an International Biotech in Denmark with Jan G. J. van de Winkel, President & Chief Executive Officer, Genmab
Ingredients for Increasing the Sustainability of the Nordic Ecosystem: Capital, Public Markets, Management, and Technology with Rolf Kjaergaard, Chief Investment Officer, Vaekstfonden
Panel sessions include:
Building a Sustainable International Company in the Nordics – Moderated by Greg Brown, Special Advisor, Investment Committee Back Bay Health Care Capital, Founder and Vice Chairman of HealthCare Royalty Partners; Graeme Brookes, Chief Executive Officer, ReApplix; Søren Møller, Managing Partner, Seed Investments, Novo Holdings; Camilla C. Collet, Partner, Gorrissen Federspiel
Cross-Border M&A: Challenges, Opportunities, and Tactics for the European Company – Moderated by Jonathan Gertler, CEO and Managing Partner, Back Bay Life Science Advisors and Managing Partner, Back Bay Health Care Capital and Henrijette Richter, Partner, Sofinnova Partners; Ian Nicholson, Chief Executive Director, F2G; Niels Bang, Partner, Gorrissen Federspiel
Contact Back Bay Life Science Advisors for content information.